Clinical Trials Directory

Trials / Completed

CompletedNCT01700842

Multicenter Study of Antimicrobial Resistance of Gram-positive and Gram-negative Clinical Strains to Ceftaroline and Other Antimicrobials in Russia

Status
Completed
Phase
Study type
Observational
Enrollment
3,000 (actual)
Sponsor
AstraZeneca · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Approximately 3,000 of clinically significant isolates of different species from respective respective sources in geographically distinct Russian cities will be collected and tested on ceftaroline and other antimicrobials.

Conditions

Timeline

Start date
2012-10-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2012-10-04
Last updated
2013-06-27

Locations

2 sites across 1 country: Russia

Source: ClinicalTrials.gov record NCT01700842. Inclusion in this directory is not an endorsement.